Since high levels of hypoxia accompanying TAM infiltration was observed to increase the aggressiveness of GC cell lines [161] and HIF-1α expression was correlated with the number of Treg in GC specimens [165], HIF-1α activity may also be a limiting factor for the efficacy of immunotherapies in GC patients. The gene discussed is HIF1A; the disease is gastric cancer.